NCT01795781View on ClinicalTrials.gov

Assays for and Reversal of New Anticoagulants

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Atrial FibrillationOsteoarthritis of the KneeOsteoarthritis of the Hip
Trial Locations (1)

6000

Royal Perth Hospital, Perth

All Listed Sponsors
lead

R.P.Herrmann

OTHER

NCT01795781 - Assays for and Reversal of New Anticoagulants | Biotech Hunter | Biotech Hunter